Paper Details

Paper Title

Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma.

Paper Journal Title

Br J Dermatol

Paper Citation Count

137

Paper Publication Year

2012

Bio Mention

BRAF, Cutaneous reactions, GSK2118436, HPV, Human papillomavirus, Patients, SCC in situ, SCCs, acneiform eruptions, dabrafenib, epidermal cysts, hair loss, keratinocytic, keratoacanthoma, metastatic melanoma, mutant BRAF, p16, patients, reactive hyperkeratotic lesions on the, seborrhoeic keratoses, skin lesions, squamous cell carcinomas, verrucal keratoses, verrucal keratotic squamoproliferative lesions

Mesh Descriptor

Paper Details

Column Actions

Datasets